Wednesday, November 18, 2009
Print Entire 2009 Program:
|
|
SESSION 1 SCHEDULE | |
Wednesday
SESSION 1:
HEMODIALYSIS ACCESS - PART 1
Moderators:TBD
|
|
x | |
7:50 AM - 7:59 AM | Introduction |
Presenters(s):Larry A. Scher, MD / Thomas M. Vesely, MD | |
PART 1A: ACCESS PLANNING, DYSFUNCTIONAL FISTULAS AND CENTRAL VENOUS CATHETERS | |
Moderator(s): Thomas M. Vesely, MD | |
8:00 AM - 8:10 AM | Results Of The Dialysis Access Consortium: Where Do We Go From Here? |
8:11 AM - 8:21 AM | Does Physical Examination Have A Role In The Planning And Evaluation Of Hemodialysis Access? |
8:22 AM - 8:32 AM | Update On Ultrasound Imaging For Hemodialysis Access |
8:33 AM - 8:43 AM | Fundamentals Of Angiographic Evaluation Of AV Access |
Presenters(s):Timothy W.I. Clark, MD | |
8:44 AM - 8:54 AM | Facilitating Endovascular Access Procedures Using Flouro Trace |
Presenters(s):Jacob Cynamon, MD | |
8:55 AM - 9:05 AM | Management Of The Immature Fistula |
Presenters(s):Theodore F. Saad, MD | |
9:06 AM - 9:16 AM | Salvaging The Unsalvageable Fistula |
9:17 AM - 9:27 AM | Dialysis Catheters Are Bad News |
9:28 AM - 9:38 AM | Catheters Don’t Kill Patients |
9:39 AM - 9:59 AM | Panel Discussion |
10:00 AM - 10:20 AM | Break / Visit Exhibits |
PART 1B: MANAGEMENT OF CENTRAL VENOUS PROBLEMS | |
Moderator(s): Theodore F. Saad, MD / Joseph N. Shams, MD | |
10:21 AM - 10:31 AM | Pathophysiology Of Fibrin Sheath Development |
10:32 AM - 10:42 AM | Removal Of Embedded Catheters |
Presenters(s):Thomas M. Vesely, MD | |
10:43 AM - 10:53 AM | Catheter Exchange Procedures |
10:54 AM - 11:04 AM | Catheter-Related Central Venous Stenosis |
11:05 AM - 11:15 AM | Pacemaker/Defibrillator Related Central Venous Stenosis |
Presenters(s):Theodore F. Saad, MD | |
11:16 AM - 11:26 AM | Power Wire For Central Venous Stenoses |
11:27 AM - 11:37 AM | Use Of The Peripheral Cutting Balloon For Treatment Of Cephalic Arch Stenosis Associated With Brachiocephalic Fistulas |
11:38 AM - 11:48 AM | Fatal Complications Of SVC Angioplasty |
Presenters(s):Jacob Cynamon, MD | |
11:49 AM - 12:10 PM | Panel Discussion |
12:10 PM - 1:05 PM | Lunch Break / Visit Exhibits |
END OF SESSION 1 | |
SESSION 2 SCHEDULE | |
Wednesday
SESSION 2:
HEMODIALYSIS ACCESS - PART 2
Moderators:TBD
|
|
x | |
PART 2A: HEMODIALYSIS ACCESS COMPLICATIONS / THROMBECTOMY PROCEDURES | |
Moderator(s): TBD / TBD | |
1:05 PM - 1:15 PM | Surgical vs. Percutaneous Thrombectomy: Which Is Best? |
1:16 PM - 1:26 PM | Techniques For Percutaneous Thrombectomy |
Presenters(s):Thomas M. Vesely, MD | |
1:27 PM - 1:37 PM | Management Of Arterial Embolization During Percutaneous Thrombectomy Of Hemodialysis Grafts And Fistulas |
Presenters(s):Joseph N. Shams, MD | |
1:38 PM - 1:43 PM | Debate: Should Interventionalists Do Surgery: Pro |
1:44 PM - 1:49 PM | Debate: Should Interventionalists Do Surgery: Con |
Presenters(s):Marc H. Glickman, MD | |
1:50 PM - 2:00 PM | Vascular Access Hemorrhagic Deaths Among Hemodialysis Patients |
2:01 PM - 2:11 PM | Are Antiplatelet Drugs Or Anticoagulation Ever Indicated To Maintain Access Patency? |
Presenters(s):Jeffrey H. Lawson, MD, PhD | |
2:12 PM - 2:32 PM | Panel Discussion |
2:33 PM - 2:55 PM | Break / Visit Exhibits |
PART 2B: UPDATE ON NEW TECHNOLOGIES (5 MINUTE TALKS) | |
Moderator(s): Larry A. Scher, MD / Marc H. Glickman, MD | |
2:56 PM - 3:01 PM | Topical rThrombin For Wound Hemostasis |
3:02 PM - 3:07 PM | Role Of Heparin Bonded ePTFE Grafts In Dialysis Access |
3:08 PM - 3:13 PM | Preliminary Experience With The Duraspan Hemodialysis Catheter |
Presenters(s):Melvin Rosenblatt, MD | |
3:14 PM - 3:19 PM | Recombinant Human Elastase For Improved Vascular Access |
Presenters(s):Jeffrey H. Lawson, MD, PhD | |
3:20 PM - 3:30 PM | Panel Discussion |
PART 2C: IMPORTANT TOPICS IN VASCULAR ACCESS | |
Moderator(s): Larry A. Scher, MD / Marc H. Glickman, MD | |
3:31 PM - 3:41 PM | Optimizing Hemodialysis Cannulation Methods: Role Of Buttonhole Cannulation |
3:42 PM - 3:52 PM | Clinical Practice Guidelines For Hemodialysis Access |
3:53 PM - 4:03 PM | Reimbursement For Vascular Access: What Does The Future Hold? |
4:04 PM - 4:14 PM | Vascular Access Surveillance And The CMS MAT-V551 Requirement |
Presenters(s):William D. Paulson, MD | |
4:15 PM - 4:25 PM | Radial-to-Cephalic Arteriovenous Fistulas As A Method Of Choice In Children And Adolescents |
4:26 PM - 4:36 PM | Perfect Dialysis Access Graft: Are We There Yet? |
4:37 PM - 4:47 PM | Ischemic Monomelic Neuropathy |
Presenters(s):Larry A. Scher, MD | |
4:48 PM - 5:10 PM | Panel Discussion |
5:10 PM - 5:10 PM | Adjourn |
END OF SESSION 2 | |
SESSION 3 SCHEDULE | |
Wednesday
SESSION 3:
MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 1
Moderators:TBD
|
|
x | |
7:50 AM - 8:00 AM | Welcome And Introduction |
Presenters(s):Allan L. Brook, MD | |
PART 1A: THE BASICS OF STROKE | |
Moderator(s): TBD / Joshua A. Hirsch, MD | |
8:00 AM - 8:10 AM | Revisiting The Common Anatomic Locations And Risk Factors That Lead To Stroke: Embolic, Thrombotic And Hypoperfusion Scenarios |
8:10 AM - 8:20 AM | Differences In The Anterior And Posterior Circulations: Does A TIA Have The Same Implications? |
Presenters(s):Lawrence Wechsler, MD | |
8:20 AM - 8:30 AM | Differential Diagnosis And Stroke Mimics: Necessity Of Early Stroke Diagnosis And Its Implications |
Presenters(s):Daniel Labovitz, MD | |
8:30 AM - 8:40 AM | Practical Considerations In The Early Treatment Of Stroke: Evolution Into The 21st Century |
8:40 AM - 8:50 AM | Importance Of Time - How To Streamline And Improve Times To Treatment: Triage Issues |
8:50 AM - 9:00 AM | Discussion |
PART 1B: STATE-OF-THE-ART NEUROIMAGING FOR STROKE: TIME VS. PHYSIOLOGY: ARE WE THERE YET? | |
Moderator(s): TBD / TBD | |
9:00 AM - 9:10 AM | What Are We Trying To Image: Lessons From Recent Trials: And Patient Selection Derived From Imaging |
9:10 AM - 9:20 AM | Acute Stroke Imaging: Perfusion And Collateral Circulation, Best Methods And Implications |
9:20 AM - 9:30 AM | Neurovascular Calcium Scoring: Does It Work For Predicting Stroke? |
9:30 AM - 9:40 AM | CTA/CTP: Pros And Cons In The Acute Setting |
Presenters(s):Todd S. Miller, MD | |
9:40 AM - 9:50 AM | MRI/MRA/DWI/Perfusion: Added Value Or Wasted Time In The Acute Setting? |
9:50 AM - 10:00 AM | Discussion |
PART 1C: CRITICAL EVALUATION OF CAROTID STENTING 2009 | |
Moderator(s): Philip M. Meyers, MD / Aman Patel, MD | |
10:00 AM - 10:10 AM | Carotid Disease And Stroke - Natural History And Implications For Intervention: Review Of The Recent And Relevant Trials |
10:10 AM - 10:15 AM | How To Predict Which Asymptomatic Patients Are At High Risk For Stroke So They Can Be Treated Early |
10:15 AM - 10:20 AM | The Case For Carotid Stenting: My Pearls! |
Presenters(s):Mark H. Wholey, MD | |
10:20 AM - 10:25 AM | Anatomic And Lesion Characteristics Are Accurate Predictors Of Stroke From CAS: What Technique Is Best For Determining This? |
Presenters(s):Mark H. Wholey, MD | |
10:25 AM - 10:35 AM | Medical Treatment vs. Intervention For Asymptomatic Carotid Stenosis: My Decision Pearls |
10:35 AM - 10:45 AM | Carotid Injury And Repair: Techniques, Technology And Beyond |
Presenters(s):Gregg H. Zoarski, MD | |
10:45 AM - 11:15 AM | Break / Visit Exhibits |
PART 1D: ACUTE STROKE THERAPEUTIC OPTIONS 2009 | |
Moderator(s): Philip M. Meyers, MD / TBD | |
11:15 AM - 11:25 AM | Current Guidelines For IV Therapy |
Presenters(s):Steven H. Rudolph, MD | |
11:25 AM - 11:35 AM | Intra-arterial Pharmacological Thrombolysis: History And Present Options |
Presenters(s):Osama O. Zaidat, MD | |
11:35 AM - 11:45 AM | IA Thrombectomy Devices: State-Of-The-Art Options And Risks |
Presenters(s):Aquilla S. Turk, DO | |
11:45 AM - 11:55 AM | Current Protocols For Reperfusion In Acute Stroke In A High Volume Tertiary Stroke Center |
11:55 AM - 12:05 PM | What Is The Best Model For A Bridging Protocol: Summary Of IMS Trials – Lessons Learned |
12:05 PM - 12:15 PM | Acute Stroke Angioplasty And Stenting: Follow The Cardiac Model? Who Should Be Credentialed? |
Presenters(s):Colin P. Derdeyn, MD | |
LUNCHEON PROGRAM: ACUTE STROKE INTERVENTIONAL TECHNIQUES: LATEST AND GREATEST | |
Moderator(s): Peter K. Nelson, MD / TBD / Joshua A. Hirsch, MD | |
12:15 PM - 12:25 PM | INR Stroke Trials: NIH Update |
12:25 PM - 12:35 PM | My Best Stroke Cases: Learning Points And Pearls |
Presenters(s):David Fiorella, MD | |
12:35 PM - 12:45 PM | Lessons Learned And How To Stay Out Of Trouble |
Presenters(s):Don Frei, MD | |
12:45 PM - 12:55 PM | Stroke Reimbursement: Fact And Fiction |
12:55 PM - 1:15 PM | Discussion |
END OF SESSION 3 | |
SESSION 4 SCHEDULE | |
Wednesday
SESSION 4:
AIMSYMPOSIUM MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 2 AND
INNOVATIVE INTERVENTIONAL MANAGEMENT OF SPINAL DISORDERS
Moderators:TBD
|
|
x | |
PART 2A: STROKE AND NEURO INTENSIVE CARE UNITS | |
Moderator(s): TBD / TBD | |
1:15 PM - 1:25 PM | How To Best Form And Utilize A Stroke Unit/Neuro ICU |
1:25 PM - 1:35 PM | How To Organize Your Stroke Center/Team: Materials And Methods, Money And Men |
1:35 PM - 1:45 PM | Neurosurgical Management Of Large Stroke Volumes And Hemicraniectomy: Indications And Issues |
1:45 PM - 1:55 PM | Discussion |
PART 2B: INTRACRANIAL ATHEROSCLEROSIS MANAGEMENT | |
Moderator(s): Aquilla S. Turk, DO / Philip M. Meyers, MD | |
1:55 PM - 2:05 PM | Natural History And Managing The Risk Factors Of Intracranial Atherosclerotic Disease (ICAD) |
Presenters(s):Daniel Labovitz, MD | |
2:05 PM - 2:15 PM | Patient Selection For Treating ICAT |
Presenters(s):Philip M. Meyers, MD | |
2:15 PM - 2:25 PM | Interventional Treatment Options For ICAT |
Presenters(s):Aquilla S. Turk, DO | |
2:25 PM - 2:35 PM | SAMMPRIS Update |
Presenters(s):Colin P. Derdeyn, MD | |
2:35 PM - 2:45 PM | Neurovascular Territories For The Interventionalist |
Presenters(s):Joshua A. Hirsch, MD | |
2:45 PM - 2:55 PM | Legal Ramification If You Do Or Do Not Treat With An FDA Approved Drug And/Or Device |
Presenters(s):Michael I. Weintraub, MD | |
2:55 PM - 3:30 PM | Discussion |
3:30 PM - 4:00 PM | Break / Visit Exhibits |
INNOVATIVE INTERVENTIONAL MANAGEMENT OF SPINAL DISORDERS: PART 1 - DISC THERAPY | |
Moderator(s): Gregg H. Zoarski, MD / Joshua A. Hirsch, MD / TBD | |
4:00 PM - 4:10 PM | Percutaneous Disc Therapy: Devices, Ozone And Beyond |
4:10 PM - 4:15 PM | Debate 1: Percutaneous Is Obviously Best! |
4:15 PM - 4:20 PM | Debate 2: Minimally Invasive Coned Surgery Is Obviously Better! |
4:20 PM - 4:30 PM | Cases And Discussion |
Panelist(s): Kieran P.J. Murphy, MD, FRCPC / Jeffrey Stone, MD / John K. Houten, MD | |
INNOVATIVE INTERVENTIONAL MANAGEMENT OF SPINAL DISORDERS: PART 2 - FAILED BACK SYNDROME | |
Moderator(s): Gregg H. Zoarski, MD / Joshua A. Hirsch, MD / TBD | |
4:30 PM - 4:40 PM | Spinal Fusion Technology: What We Need To Understand And New Techniques |
4:40 PM - 4:50 PM | Postoperative Pain And Interventional Therapy |
Presenters(s):Allan L. Brook, MD | |
4:50 PM - 5:00 PM | Panel Discussion |
Panelist(s): Alok Sharan, MD / Allan L. Brook, MD | |
INNOVATIVE INTERVENTIONAL MANAGEMENT OF SPINAL DISORDERS: PART 3 - VERTEBRAL AUGMENTATION: FACTS AND FICTION | |
Moderator(s): Gregg H. Zoarski, MD / Joshua A. Hirsch, MD / Allan L. Brook, MD | |
5:00 PM - 5:10 PM | Percutaneous Treatment Of VBF: Past, Present And Future |
5:10 PM - 5:20 PM | Latest Technology And Innovative Techniques |
Presenters(s):R. Sean Pakbaz, MD | |
QUESTION AND ANSWER | |
5:20 PM - 5:30 PM | Best Cement Choice, And Why? |
5:30 PM - 5:40 PM | Best Device Choice, And Why? |
CASE PRESENTATION AND PANEL DISCUSSION | |
5:40 PM - 6:00 PM | If My Mother Has A Vertebral Compression Fraction, Would I Recommend Treatment: Evidence And Support |
Panelist(s): Orlando Ortiz, MD / Jeffrey Stone, MD / Kieran P.J. Murphy, MD, FRCPC | |
END OF SESSION 4 | |
SESSION 5 SCHEDULE | |
Wednesday
SESSION 5:
ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 1
Moderators:Jose I. Almeida, MD, FACS, RVT / TBD
|
|
x | |
8:00 AM - 8:09 AM | Welcoming Remarks |
Presenters(s):Jose I. Almeida, MD, FACS, RVT | |
8:10 AM - 8:19 AM | How To Identify The Best Patients For Endovenous Thermal Ablation |
8:20 AM - 8:29 AM | Which Patients Are Not Suitable For Endovenous Thermal Ablation? |
Presenters(s):Jose I. Almeida, MD, FACS, RVT | |
8:30 AM - 8:39 AM | Generating The Venous Map With Duplex Ultrasound |
Presenters(s):Neil M. Khilnani, MD | |
8:40 AM - 8:49 AM | Great Saphenous vs. Small Saphenous Vein Ablation: Similarities And Differences Of Procedure |
8:50 AM - 8:59 AM | Endovenous Thermal Ablation: How I Choose Between RF Or Laser |
9:00 AM - 9:09 AM | Catheter-Directed Foam Sclerotherapy Treatment Of Saphenous Vein Incompetence |
9:10 AM - 9:19 AM | Lessons Learned After 3,000 Endovenous Ablations |
9:20 AM - 9:35 AM | Panel Discussion |
9:36 AM - 9:45 AM | Fire, Foam, And Knife For Varicose Veins: What Have Prospective Randomized Clinical Trials Taught Us? |
9:46 AM - 9:55 AM | What Studies Are Needed To Help Vein Doctors Treat Patients Better? |
9:56 AM - 10:05 AM | Preservation Of The Saphenous Vein In Patients With Varicose Veins |
10:06 AM - 10:15 AM | The CHIVA Approach To Varicose Vein Treatment |
10:16 AM - 10:25 AM | Matrix Metalloproteinases And Varicose Veins |
10:26 AM - 10:35 AM | Current Information On The Development And Treatment Of Venous Ulcers |
10:36 AM - 10:45 AM | How To Treat Ascending GSV Superficial Thrombophlebitis |
10:46 AM - 10:54 AM | Ileofemoral Venous Reflux And Obstruction: Diagnosis And Treatment |
10:55 AM - 11:04 AM | Venous Stenting: When, Where, Whom, How? |
11:05 AM - 11:14 AM | Deep Vein Considerations During Superficial Venous Treatment |
Presenters(s):Jose I. Almeida, MD, FACS, RVT | |
11:15 AM - 11:24 AM | The Future Of Venous Imaging: Will It Be Duplex Ultrasound, MRV, Or CTV? |
Presenters(s):Barry Stein, MD, FSIR, FACR | |
11:25 AM - 11:34 AM | Pelvic Venous Syndromes |
Presenters(s):Melvin Rosenblatt, MD | |
11:35 AM - 11:44 AM | Are Surgeons Letting Vein Care Slip Away?: Are Phlebologists Taking Over? |
11:45 AM - 12:00 PM | Panel Discussion |
12:00 PM - 12:30 PM | Lunch Break |
END OF SESSION 5 | |
SESSION 6 SCHEDULE | |
Wednesday
SESSION 6:
ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 2
Moderators:Jose I. Almeida, MD, FACS, RVT / TBD
|
|
x | |
12:30 PM - 12:39 PM | DVT Update: Current Recommendations For Treatment And Prophylaxis |
12:40 PM - 12:49 PM | Current Data On Radiofrequency Ablation With The ClosureFAST Catheter |
12:50 PM - 12:59 PM | Venous Laser Updates: New Wavelength Or Fibers? |
1:00 PM - 1:09 PM | Management Of The Anticoagulated Patient Who Needs Endovenous Ablation And Phlebectomy |
1:10 PM - 1:19 PM | Phlebectomy, Trivex, Or Sclerotherapy For Bulging Varicose Vein Tributaries? |
1:20 PM - 1:29 PM | Foam vs. Liquid Sclerotherapy In The Management Of Varicose Veins |
Presenters(s):Jose I. Almeida, MD, FACS, RVT | |
1:30 PM - 1:39 PM | Considerations For Treatment Of Infrapopliteal Deep Venous Thrombosis |
1:40 PM - 1:49 PM | Thrombotic Complications Of Endovenous Therapy For Varicose Veins |
1:50 PM - 1:59 PM | Thrombophilia: When To Order? What To Order? How To Treat And For How Long? |
2:00 PM - 2:09 PM | Should Adjuvant Procedures Be Performed At The Same Time As Endothermal Ablation?: Evidence Based |
2:10 PM - 2:19 PM | When Should Perforators Be Considered For Treatment? |
2:20 PM - 2:29 PM | Recurrent Varicose Veins: Can They Be Prevented? Can They Be Treated Effectively? |
2:30 PM - 2:39 PM | Role Of Laser vs. Sclerotherapy For Spider Telangiectasias? |
2:40 PM - 2:49 PM | Management Of Venous Malformations: Cut, Cook, Squirt? |
Presenters(s):Joshua L. Weintraub, MD, FSIR | |
2:50 PM - 3:00 PM | Complications Of Foam Sclerotherapy: What I Have Witnessed |
3:00 PM - 3:10 PM | Establishing VTE Protocols For Prevention And Intervention |
3:10 PM - 3:20 PM | Building Your DVT Practice |
3:20 PM - 3:50 PM | Ask The Panel |
Panelist(s): Jose I. Almeida, MD, FACS, RVT / Lowell S. Kabnick, MD, FACS, FACPh / Ronald G. Bush, MD / Edward G. Mackay, MD / Thomas F. O'Donnell, Jr., MD / Peter F. Lawrence, MD / Peter J. Pappas, MD / Peter H. Lin, MD | |
3:50 PM - 3:50 PM | Adjourn |
END OF SESSION 6 | |
Thursday, November 19, 2009
Print Entire 2009 Program:
|
|
SESSION 7 SCHEDULE | |
x | |
7:35 AM - 7:40 AM | Opening Remarks |
Presenters(s):Jacob Cynamon, MD | |
7:40 AM - 8:40 AM | Case Presentations: Multidisciplinary Approach Yields The Best Approach |
Presenters(s):Jean Francois H. Geschwind, MD / | |
END OF SESSION 7 | |
SESSION 8 SCHEDULE | |
x | |
8:40 AM - 9:40 AM | Hands-On Percutaneous Tumor Ablation: RF, Cryo, Microwave, IRE |
Presenters(s):Joshua L. Weintraub, MD, FSIR / | |
END OF SESSION 8 | |
SESSION 9 SCHEDULE | |
Thursday
SESSION 9:
ONCOLOGY WORKSHOP 3
|
|
x | |
9:40 AM - 10:40 AM | Chemoembolization And Y90 |
Presenters(s):Jean Francois H. Geschwind, MD / Karen T. Brown, MD / Jonathan Susman, MD | |
END OF SESSION 9 | |
SESSION 10 SCHEDULE | |
Thursday
SESSION 10:
HOT TOPICS IN LOWER EXTREMITY ENDOVASCULAR TREATMENT (5-MINUTE TALKS)
Moderators: / Jacob Cynamon, MD
|
|
x | |
6:40 AM - 6:45 AM | Opening Remarks |
Presenters(s):Frank J. Veith, MD | |
6:45 AM - 6:50 AM | Overview Of Atherectomy Devices: What Is The Evidence They Add Anything But Cost? |
6:51 AM - 6:56 AM | Debate 4: Rotational Atherectomy Devices Really Work In Certain Specific Situations: What Are They? What Is The Proof? |
6:57 AM - 7:03 AM | Debate 4: Atherectomy Devices Are A Waste Of Time And Money |
7:04 AM - 7:09 AM | Value And Limitations Of The ANGIOSCULPT Scoring/Cutting PTA Balloon For Infrapopliteal Lesions: 2-Year Results Of The MASCOT Trial: Will This Decrease The Need For Stents? |
7:10 AM - 7:15 AM | Cool Excimer Laser Assisted PTA vs. Balloon PTA With New Improved Balloons For Tibial Occlusive Disease Causing Critical Limb Ischemia (CLI): Is The Laser Of Real Value And When? |
7:16 AM - 7:21 AM | Tips, Tricks And Bailout Strategies For Subintimal Angioplasty Of Long Infrainguinal Occlusions |
7:22 AM - 7:27 AM | Debate 5: Update And 12-Month Results With Drug Eluting Balloons Show Clear Benefit For Treating SFA And Popliteal Lesions |
7:28 AM - 7:33 AM | Debate 5: It Is Not So Clear That Drug Eluting Balloons Work |
7:34 AM - 7:39 AM | Prevention And Treatment Of In-Stent Restenosis |
7:40 AM - 7:45 AM | Will Long Nitinol Stents (Like the 20 cm EVERFLEX) Replace Bypass Surgery For Long Fempop Occlusions? |
7:46 AM - 7:58 AM | Panel Discussion |
END OF SESSION 10 | |
SESSION 11 SCHEDULE | |
Thursday
SESSION 11:
MORE LOWER EXTREMITY HOT TOPICS, ESPECIALLY REGARDING STENTS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
7:59 AM - 8:04 AM | Role Of Current Stents In Lower Extremity Occlusive Disease In 2009: What Is The Most Recent Evidence Including That From The STRIDES And VIASTAR Studies? |
8:05 AM - 8:10 AM | 2-Year Results Of The ZILVER-PTX Drug-Eluting Stent For SFA Lesions |
Presenters(s):Michael D. Dake, MD | |
8:11 AM - 8:16 AM | Status Of The TURBO BOOSTER Spectranetics Laser For Lower Extremity Occlusive Disease: Has It Changed Things? |
8:17 AM - 8:22 AM | New Concepts In Stent Design: The Micromesh-Covered SESAME Stent: Design And Clinical Experience |
8:23 AM - 8:28 AM | Technical Tips And Results Of Transpedal Approach For Revascularizing Tibial Artery Occlusions Which Cannot Be Crossed From Above |
8:29 AM - 8:34 AM | Indication And Techniques For Transpedal Approach In The Treatment Of Critical Limb Ischemia |
8:35 AM - 8:40 AM | New Technique For Distal PTA Of Tibial Arteries: The Pedal Arch Route For Access: Can It Work In Diabetics? |
8:41 AM - 8:46 AM | Need For Distal Embolic Filtration Devices With Lower Extremity Atherectomy And Laser Angioplasty |
8:47 AM - 8:52 AM | Incidence Of Embolization After Lower Extremity Percutaneous Revascularization |
8:53 AM - 8:58 AM | Choice Of Access For Below-Knee Interventions: Up And Over vs. Antegrade |
8:59 AM - 9:10 AM | Panel Discussion |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Thursday
SESSION 12:
MORE LOWER EXTREMITY HOT TOPICS (5-MINUTE TALKS)
Moderators:Frank J. Veith, MD / TBD
|
|
x | |
9:10 AM - 9:15 AM | Devices And Simplified Strategies For Crossing Total Occlusions |
9:16 AM - 9:21 AM | Value And Limitations Of Drug-Eluting Stents (DES) In The Treatment Of Critical Limb Ischemia (CLI) |
9:22 AM - 9:27 AM | DES vs. Bare Metal Stents (BMS) To Treat Below-Knee Lesions: 1-Year Angiographic Results Of The DESTINY Trial |
9:28 AM - 9:33 AM | Below-Knee DES For CLI: Results With 2-Year Follow-Up |
9:34 AM - 9:39 AM | Intraoperative Stem Cell Treatment Delivered With A Novel Device To Improve Limb Salvage Rates |
9:40 AM - 9:45 AM | Debate 6: DES In The SFA Will Have A Positive Impact |
9:46 AM - 9:51 AM | Debate 6: DES In The SFA Are Not Needed |
9:52 AM - 9:57 AM | 5-Year Results With Zilver Stents Across The Knee Are Good |
9:58 AM - 10:03 AM | With Foot Gangrene And Ulceration Wound Healing Occurs Faster And Better With A Bypass Than With Endovascular Treatments |
10:04 AM - 10:18 AM | Panel Discussion CONCLUSION OF PROGRAMS A AND B. AIMsymposium continues in the Trianon Ballroom, 3rd Floor as Plenary Sessions. VEITHsymposium continues in the Grand Ballroom, 3rd Floor as Plenary Sessions. |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Thursday
SESSION 13:
IMAGING FOR VASCULAR INTERVENTION
Moderators:TBD
|
|
x | |
11:00 AM - 11:10 AM | Preprocedural Imaging MRA Or CTA: Which Is Best For Evaluation Of PVD? |
Presenters(s):Barry Stein, MD, FSIR, FACR | |
11:10 AM - 11:20 AM | Preprocedural Imaging MRA Or CTA: Which Is Best For Evaluation Of Aortic And Visceral Disease? |
Presenters(s):Robert A. Lookstein, MD, FSIR, FAHA | |
11:20 AM - 11:30 AM | Improved MRA With Improved Blood Pool Contrast |
11:30 AM - 11:40 AM | In Patients With Renal Insufficiency, MRA Can Be Performed Adequately Without Contrast |
Presenters(s):Eli Atar, MD | |
11:40 AM - 11:50 AM | How To Grow Your Interventional Practice Using Cross-Sectional Imaging |
Presenters(s):Timothy W.I. Clark, MD | |
11:50 AM - 12:00 PM | The IR Suite Of The Future Is Here Today: How We Have Incorporated Imaging And Surgery In Our Center |
Presenters(s):Barry T. Katzen, MD | |
12:00 PM - 12:10 PM | Technical Tips For CO2 Angiography |
Presenters(s):James Caridi, MD | |
12:10 PM - 12:20 PM | The Value Of Fluoro CT For Vascular And Non Vascular Intervention |
12:20 PM - 12:30 PM | Fluoro-TRACE: A New Roadmapping Technique That Simplifies Vascular Intervention |
Presenters(s):Jacob Cynamon, MD | |
12:30 PM - 12:40 PM | Panel Discussion |
12:40 PM - 1:20 PM | Lunch Break |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Thursday
SESSION 14:
SFA/POPLITEAL/TIBIAL DISEASE
Moderators:TBD
|
|
x | |
1:20 PM - 1:30 PM | What Is The Best Medical Treatment For PVD? |
Presenters(s):Andrew S. Blum, MD | |
1:30 PM - 1:40 PM | Intermittent Claudication: What Have We Learned From The Randomized Trials? |
Presenters(s):Timothy P. Murphy, MD | |
1:40 PM - 1:50 PM | New And Improved Stents Can Improve Results Of SFA Stenting |
Presenters(s):Götz M. Richter, MD, PhD | |
1:50 PM - 2:00 PM | The Contemporary “CLI Tool Box”: New Devices Including Atherectomy Devices And New Crossing Systems |
Presenters(s):Gary M. Ansel, MD | |
2:00 PM - 2:10 PM | Crossing Long Tibial Occlusions: Technical Tips |
Presenters(s):Gary M. Ansel, MD | |
2:10 PM - 2:20 PM | The Micromesh-Covered Stent (SESAME Stent): A New Concept In Stent Design |
2:20 PM - 2:30 PM | Current Status Of Angiogenesis In Patients With Non Reconstructible PVD |
2:30 PM - 2:40 PM | Popliteal Aneurysms: Stent-Grafts Should Be The Preferred Mode Of Treatment |
Presenters(s):Barry T. Katzen, MD | |
2:40 PM - 2:50 PM | Duplex Guided PTA: Is It Truly Feasible Or Is It A Hoax? |
2:50 PM - 3:00 PM | Outpatient Endovascular Procedures: What Can And Cannot Be Done In The Outpatient Center? |
3:00 PM - 3:30 PM | Panel Discussion |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
x | |
3:30 PM - 3:40 PM | Improving Renal Perfusion During Contrast Studies May Help Preserve Renal Function In Patients With Renal Insufficiency |
Presenters(s):John H. Rundback, MD, FSIR, FAHA | |
3:40 PM - 3:50 PM | Renal Intervention: Techniques And Results Of A Large Single Center Study |
Presenters(s):Thomas A. Sos, MD | |
3:50 PM - 4:00 PM | New Improved Renal Stent Systems: Is Smaller Better? |
Presenters(s):Götz M. Richter, MD, PhD | |
4:00 PM - 4:10 PM | What Have We Learned From The Randomized Renal Artery Stent Trials? |
Presenters(s):Timothy P. Murphy, MD | |
4:10 PM - 4:20 PM | Panel Discussion |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
x | |
4:20 PM - 4:30 PM | Venous Thromboembolic Disease: Randomized Prospective Trial To Determine Efficacy Of Aggressive Management Of DVT |
4:30 PM - 4:40 PM | Tips And Tricks For Stenting Chronic Venous Occlusions |
4:40 PM - 4:50 PM | Outpatient Treatment Of DVT |
4:50 PM - 5:00 PM | Optional IVC Filter Removal: Tips For Difficult Cases |
Presenters(s):David W. Trost, MD | |
5:00 PM - 5:10 PM | Fatal Complications Of Interventional Management Of SVC Syndrome |
Presenters(s):Jacob Cynamon, MD | |
5:10 PM - 5:20 PM | Panel Discussion |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
Thursday
SESSION 17:
UTERINE FIBROID EMBOLIZATION/PELVIC ARTERIOVENOUS MALFORMATION
Moderators:TBD
|
|
x | |
5:20 PM - 5:30 PM | Pelvic Congestion Syndrome And Varicoceles: New Treatment Techniques Based On Recent Data |
5:30 PM - 5:40 PM | Step-By-Step Principles And New Approaches In Treating High Flow Pelvic AVMs |
Presenters(s):Robert J. Rosen, MD | |
5:40 PM - 5:50 PM | Overview Of Uterine Fibroids And Their Management |
Presenters(s):David N. Siegel, MD | |
5:50 PM - 6:00 PM | We Can Now Recommend UFE To Patients Who Want To Maintain Or Improve Their Fertility – Or Can We? |
6:00 PM - 6:10 PM | Tried And True Embolic Agent For UFE: Why Gamble When The Results Are So Good? |
6:10 PM - 6:20 PM | We Can Do Better: A New Embolic Agent With Improved Features |
Presenters(s):Götz M. Richter, MD, PhD | |
6:20 PM - 6:30 PM | Comparing New Entrants To Established Standards: Quantitative In Vitro And In Vivo Comparisons Of Embozene To Embosphere |
6:30 PM - 6:40 PM | Panel Discussion |
END OF SESSION 17 | |
Friday, November 20, 2009
Print Entire 2009 Program:
|
|
SESSION 18 SCHEDULE | |
x | |
7:30 AM - 7:40 AM | Stent-Graft vs. Nitinol Stent For SFA Occlusive Disease: Results Of The VIBRANT Trial |
7:40 AM - 7:50 AM | Edge Stenosis After SFA Stents Or Stent-Grafts: Prevention And Management |
Presenters(s):Richard R. Saxon, MD | |
7:50 AM - 8:00 AM | Subintimal Angioplasty For SFA And Tibial Revascularization: Techniques For Improved Results |
8:00 AM - 8:20 AM | Panel Discussion |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Friday
SESSION 19:
AORTA
Moderators:TBD
|
|
x | |
8:20 AM - 8:30 AM | Endovascular Management Of Type B Dissections: What Works Best? |
8:30 AM - 8:40 AM | Aortic Arch Aneurysms Can Be Treated With Branched Endografts |
8:40 AM - 8:50 AM | Clinical Experience With A New Fenestrated Endograft For Pararenal AAA |
8:50 AM - 9:00 AM | Do Small AAAs Need To Be Treated: Results Of Randomized Trials |
9:00 AM - 9:10 AM | Aortic Coarctation Is Best Managed With Serial Dilatation Of An ICAST Covered Stent |
Presenters(s):Elchanan Bruckheimer, MBBS | |
9:10 AM - 9:20 AM | Are There Conditions That Predispose To Type II Endoleaks |
Presenters(s):Robert A. Lookstein, MD, FSIR, FAHA | |
9:20 AM - 9:30 AM | How And Why I Use Onxy To Treat Type II Endoleaks |
Presenters(s):Plinio Rossi, MD | |
9:30 AM - 9:40 AM | How And Why I Use Glue To Treat Type II Endoleaks |
Presenters(s):Robert J. Rosen, MD | |
9:40 AM - 10:00 AM | Panel Discussion |
10:10 AM - 10:30 AM | Break |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Friday
SESSION 20:
RENAL TUMORS
Moderators:TBD
|
|
x | |
10:30 AM - 10:40 AM | Preoperative Renal Embolization For Renal Cell Tumors |
Presenters(s):Curtis W. Bakal, MD, MPH | |
10:40 AM - 10:50 AM | Percutaneous Temporary Vessel Occlusion With A Reversible Thermoplastic Polymer For Bloodless Minimal Invasive Renal Surgery (LEGOO) |
Presenters(s):Sebastian Flacke, MD, PhD | |
10:50 AM - 11:00 AM | Management Of Renal Tumors – Transarterial And Percutaneous: The Whole Gamut |
11:00 AM - 11:10 AM | Debate: Percutaneous Cryotherapy Has An Important Role In The Management Of Renal Tumors |
Presenters(s):Timothy W.I. Clark, MD | |
11:10 AM - 11:20 AM | Debate: Percutaneous Cryotherapy Has A Minimal (If Any) Role In The Management Of Renal Tumors |
Presenters(s):Reza Ghavamian, MD | |
11:20 AM - 11:30 AM | Panel Discussion |
END OF SESSION 20 | |
SESSION 21 SCHEDULE | |
x | |
11:30 AM - 11:40 AM | Pathophysiology Of Portal Hypertension |
Presenters(s):John F. Reinus, MD | |
11:40 AM - 11:50 AM | Portal Vein And SVM Thrombosis: Should I Treat It, And If So, How? |
11:50 AM - 12:00 PM | Why And How To Narrow A TIPS |
Presenters(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
12:00 PM - 12:10 PM | (BRTO) Balloon-Occluded Retrograde Transvenous Obliteration For The Treatment Of Gastric And Esophageal Varices: Indications And Techniques |
12:10 PM - 12:20 PM | Panel Discussion |
12:20 PM - 1:00 PM | Lunch Break |
END OF SESSION 21 | |
SESSION 22 SCHEDULE | |
Friday
SESSION 22:
INTERVENTIONAL ONCOLOGY: LIVER AND CANCER METASTASES
Moderators: / Jean Francois H. Geschwind, MD
|
|
x | |
1:00 PM - 1:10 PM | Liver Transplant And The Interventional Radiologist |
Presenters(s):Paul J. Gaglio, MD | |
1:10 PM - 1:20 PM | UNOS Criteria For Liver Transplantation: How It Effects Choice Of Surgery vs. Local Regional Therapy |
Presenters(s):Milan Kinkhabwala, MD | |
1:20 PM - 1:30 PM | Percutaneous Management Of Post Liver Transplant Complications |
Presenters(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
1:30 PM - 1:40 PM | Volumetric Measurements And Portal Vein Embolization To Facilitate Partial Hepatectomy |
1:40 PM - 1:50 PM | CO2 DSA For Interventional Oncology |
Presenters(s):James Caridi, MD | |
1:50 PM - 2:00 PM | PRECISION V Study: Conventional TACE vs. DC Beads For Treatment Of HCC: A Randomized Trial |
2:00 PM - 2:10 PM | RFA For HCC |
2:10 PM - 2:20 PM | Cyberknife vs. Percutaneous Ablation Techniques: Results In Lung And Liver Tumors |
2:20 PM - 2:30 PM | Percutaneous Hepatic Artery Infusion Of Chemotherapy With Venous Filtration: The Delcath System |
2:30 PM - 2:40 PM | IRE: Is It The Holy Grail For The Treatment Of Pancreatic Cancer? |
2:40 PM - 2:50 PM | Fiducial Implantation For Sterotactic Radiotherapy: How I Do It |
2:50 PM - 3:00 PM | Drug Eluting Beads: The Italian Experience Using Combined Therapy |
Presenters(s):James Caridi, MD | |
3:00 PM - 3:10 PM | Bland Embolization And RFA At Same Session: Advantages And Disadvantages |
3:10 PM - 3:20 PM | Hepatic Arterial Management Of Metastatic Neuroendocrine Tumors |
Presenters(s):Karen T. Brown, MD | |
3:20 PM - 3:30 PM | Y90 Embolization For Hepatic Metastases |
3:30 PM - 3:40 PM | Tissue Characteristics After Ablation (RF, Cryo, MW, IRE) Of Liver Tumors: Is There Prognostic Value? |
Presenters(s):Constantinos T. Sofocleous, MD, PhD | |
3:40 PM - 3:50 PM | Interventional Oncology + Molecular Imaging = The Future Of Cancer Therapy |
3:50 PM - 4:00 PM | What, If Any Interventional Oncology Procedures Can Be Done In An Outpatient Setting? |
4:00 PM - 4:10 PM | The Future Of Interventional Oncology |
Presenters(s):Jean Francois H. Geschwind, MD | |
4:10 PM - 4:20 PM | Panel Discussion And Closing Remarks |
4:20 PM - 4:20 PM | Adjourn |
END OF SESSION 22 | |